Your browser doesn't support javascript.
loading
High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial.
You, Jing; Zhu, Shuchai; Li, Jiancheng; Li, Jie; Shen, Junyue; Zhao, Yidian; Li, Xiaomin; Jia, Lin; Li, Qingshan; Yang, Jun; Wu, Yiqun; Shen, Wenbin; Wu, Haishan; Wu, Xueqin; Wang, Xiaomin; Ren, Yaqiong; He, Jun; Lin, Pingping; Zhu, Guangying; Shi, Anhui.
Afiliación
  • You J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
  • Zhu S; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Li J; College of Clinical Medicine for Oncology, Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Li J; Department of Radiation Oncology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Shen J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
  • Zhao Y; Department 1st Radiation Therapy, Anyang Tumor Hospital, Anyang, China.
  • Li X; Chest Radiotherapy Ward 2, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Jia L; Department of Oncology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, China.
  • Li Q; Department of Oncology, Affiliated Hospital of Chengde Medical University, Chengde, China.
  • Yang J; Department of Radiotherapy, The First Affiliated Hospital of Xinxiang Medical College, Weihui, China.
  • Wu Y; Department of Epidemiology & Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
  • Shen W; Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wu H; College of Clinical Medicine for Oncology, Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Wu X; Department of Radiation Oncology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Wang X; Department 1st Radiation Therapy, Anyang Tumor Hospital, Anyang, China.
  • Ren Y; Chest Radiotherapy Ward 2, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • He J; Department of Oncology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan, China.
  • Lin P; Department of Oncology, Affiliated Hospital of Chengde Medical University, Chengde, China.
  • Zhu G; Department of Radiation Oncology, China-Japan Friendship Hospital, Beijing, 100029, China. Electronic address: zryyfa@163.com.
  • Shi A; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: anhuidoctor@163.com.
Int J Radiat Oncol Biol Phys ; 115(5): 1129-1137, 2023 04 01.
Article en En | MEDLINE | ID: mdl-36402359

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Radioterapia de Intensidad Modulada / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Radioterapia de Intensidad Modulada / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos